Table 1.
Demographic and clinical characteristics and BG levels of study patients
| Parameter | Value for groupa with: |
P | ||
|---|---|---|---|---|
| Proven candidemia | Possible candidemia | Candidemia excluded | ||
| No. of patients (n = 152) | 53 | 47 | 52 | NS |
| Median age, yr (range) | 72 (35-88) | 64 (18-88) | 59.5 (19-92) | 0.013 |
| Gender (no. male/no. female) | 27/26 | 27/20 | 32/20 | NS |
| Median total hospital stay, days (range) | 60 (11-398) | 56 (9-600) | 45 (10-268) | NS |
| Median days to BG assayb (range) | 28 (4-182) | 21 (3-398) | 15.5 (3-187) | 0.010 |
| Median days to blood culturec (range) | 27 (4-179) | NAf | NA | NA |
| No. (%) of patients with: | ||||
| ICU stayd | 11 (20.7) | 7 (14.9) | 6 (11.5) | NS |
| Abdominal surgery | 17 (32) | 18 (38) | 13 (21) | NS |
| Multifocal colonizatione | 38 (72) | 25 (53) | 19 (52) | <0.001 |
| Positive BG test | 41 (77) | 38 (81) | 9 (17) | <0.001 |
| Median BG value, pg/ml (range) | 324 (6-523) | 162 (6-523) | 27 (6-237) | <0.001 |
a
See Materials and Methods.
b
Days elapsed from admission to BG assay performance.
c
Days elapsed from admission to first blood culture positive for Candida.
d
Minimum of 48 h.
e
Isolation of at least 2 Candida spp. in noncontiguous sites.
f
NA, not applicable.